From the creators of PureWay-C, ONE Innovation Labs delivers pharmaceutical-grade liposomal technology to the body's most critical antioxidant Following our deep dive into ONE Innovation Labs and their game-changing PureWay-C technology, we're continuing our coverage with their next breakthrough: LiposoMax Glutathione
PMID: Summary Keywords drug-induced liver injury, StevensJohnson syndrome, toxic epidermal necrolysis, immune checkpoint inhibitors, moxifloxacin Citation Li Q, Wang L, Xu H, Huang T, Hong H, Ji X and Liu J (2026) Concurrent moxifloxacin-induced liver injury and toxic epidermal necrolysis after immune checkpoint inhibition: a case report and literature review
Self-administration means you control timing and technique
It was first identified in the 1970s and has since been shown to have wide-reaching benefits in tissue repair, skin rejuvenation and - most notably- hair regrowth